Havla, J., L. A. Gerdes, I. Meinl, M. Krumbholz, H. Faber, F. Weber, H. L. Pellkofer, R. Hohlfeld and T. Kümpfel: De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. In: Journal of Neurology 258, 9, 1665-1669 (2011).
Pröbstel, A. K., K. Dornmair, R. Bittner, P. Sperl, D. Jenne, S. Magalhaes, A. Villalobos, C. Breithaupt, R. Weissert, U. Jacob, M. Krumbholz, T. Kuempfel, A. Blaschek, W. Stark, J. Gartner, D. Pohl, K. Rostasy, F. Weber, I. Forne, M. Khademi, T. Olsson, F. Brilot, E. Tantsis, R. C. Dale, H. Wekerle, R. Hohlfeld, B. Banwell, A. Bar-Or, E. Meinl and T. Derfuss: Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. In: Neurology 77, 6, 580-588 (2011).
Meinl, E., T. Derfuss, M. Krumbholz, A. K. Pröbstel and R. Hohlfeld: Humoral autoimmunity in multiple sclerosis. In: Journal of the Neurological Sciences 306, 1-2, 180-182 (2011).
Pellkofer, H. L., M. Krumbholz, A. Berthele, B. Hemmer, L. A. Gerdes, J. Havla, R. Bittner, M. Canis, E. Meinl, R. Hohlfeld and T. Kuempfel: Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. In: Neurology 76, 15, 1310-1315 (2011).
Mohan, H., M. Krumbholz, R. Sharma, S. Eisele, A. Junker, M. Sixt, J. Newcombe, H. Wekerle, R. Hohlfeld, H. Lassmann and E. Meinl: Extracellular Matrix in Multiple Sclerosis Lesions: Fibrillar Collagens, Biglycan and Decorin are Upregulated and Associated with Infiltrating Immune Cells. In: Brain Pathology 20, 5, 966-975 (2010).
Mohan, H., M. Krumbholz, R. Sharma, S. Eisele, A. Junker, M. Sixt, J. Newcombe, H. Wekerle, R. Hohlfeld, H. Lassmann and E. Meinl: Extracellular Matrix in Multiple Sclerosis Lesions: Fibrillar Collagens, Biglycan and Decorin are Upregulated and Associated with Infiltrating Immune Cells. In: Brain Pathology 20, 5, 966-975 (2010).
Schankin, C. J., M. Krumbholz, P. Sostak, V. M. Reinisch, R. Goldbrunner and A. Straube: Headache in patients with a meningioma correlates with a bone-invasive growth pattern but not with cytokine expression. In: Cephalalgia 30, 4, 413-424 (2010).
Junker, A., M. Krumbholz, S. Eisele, H. Mohan, F. Augstein, R. Bittner, H. Lassmann, H. Wekerle, R. Hohlfeld and E. Meinl: MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. In: Brain 132, 3342-3352 (2009).
Kessenbrock, K., M. Krumbholz, U. Schönermarck, W. Back, W. L. Gross, Z. Werb, H. J. Gröne, V. Brinkmann and D. E. Jenne: Netting neutrophils in autoimmune small-vessel vasculitis. In: Nature Medicine 15, 6, 623-625 (2009).
Derfuss, T., K. Parikh, S. Velhin, M. Braun, E. Mathey, M. Krumbholz, T. Kümpfel, A. Moldenhauer, C. Rader, P. Sonderegger, W. Pöllmann, C. Tiefenthaller, J. Bauer, H. Lassmann, H. Wekerle, D. Karagogeos, R. Hohlfeld, C. Linington and E. Meinl: Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. In: Proceedings of the National Academy of Sciences of the United States of America 106, 20, 8302-8307 (2009).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.